Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Social Media Group Reviewing Its First iPhone App As DTC Marketing Tool, But It's Not The First To Be Released

Executive Summary

FDA has started wading into the iPhone business, at least to help determine how drug companies can use the App Store. FDA's social media working group is reviewing its first submission for an iPhone app as a direct-to-consumer marketing tool, Division of Drug Marketing, Advertising and Communications special assistant Jean-Ah Kang told the DTC National Conference April 9
Advertisement

Related Content

Downloading Confusion: Are Mobile Drug Dose Calculators Medical Devices?
Downloading Confusion: Are Mobile Drug Dose Calculators Medical Devices?
FDA's Internet Promotion Guidance: One Down By Year-End; Four More To Go?
FDA's Internet Promotion Guidance: One Down By Year-End; Four More To Go?
DDMAC Dislike: FDA Cracks Down On Facebook Widget Used On Tasigna Website
NICE Accepts Fewer Side Effects In Recommending Sanofi-Aventis's Multaq
Upcoming FDA Internet Marketing Meeting Generates Buzz At DTC Summit

Topics

Advertisement
UsernamePublicRestriction

Register

PS052138

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel